Protagenic Therapeutics, Inc. Profile Avatar - Palmy Investing

Protagenic Therapeutics, Inc.

Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound is PT00114, a synthetic form of teneurin carboxy-terminal …

Biotechnology
US, New York [HQ]
Competitors · Subsidiaries · Locations

Business Intelligence

U.S. · Business Intelligence
Worldwide · Business Intelligence
Worldwide · Subsidiaries Table
Subsidiary Private? Country City
- - - -
End of PTIX's Analysis
CIK: 1022899 CUSIP: 74365N103 ISIN: US74365N2027 LEI: - UEI: -
Secondary Listings
PTIX has no secondary listings inside our databases.